Migratory thrombophelibitis is seen in –
**Core Concept**
Migratory thrombophlebitis is a condition characterized by the formation of blood clots in multiple veins, often accompanied by inflammation and pain. It is a clinical manifestation of a larger underlying condition, typically a malignancy or a hypercoagulable state.
**Why the Correct Answer is Right**
Migratory thrombophlebitis is often associated with malignancies, such as pancreatic cancer, which can lead to a hypercoagulable state. This condition is also known as Trousseau's syndrome. The exact mechanism is not fully understood, but it is believed to involve the release of pro-coagulant substances by tumor cells, leading to the formation of blood clots in the veins. The clots can migrate to different parts of the body, causing recurrent episodes of pain and swelling.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because migratory thrombophlebitis is not typically seen in patients with a history of deep vein thrombosis (DVT). While DVT can be a risk factor for pulmonary embolism, it is not directly associated with migratory thrombophlebitis.
* **Option B:** This option is incorrect because migratory thrombophlebitis is not a common complication of varicose veins. Varicose veins can lead to chronic venous insufficiency, but they are not typically associated with the formation of blood clots in multiple veins.
* **Option C:** This option is incorrect because migratory thrombophlebitis is not typically seen in patients with a history of liver disease. While liver disease can lead to a hypercoagulable state, migratory thrombophlebitis is more commonly associated with malignancies.
**Clinical Pearl / High-Yield Fact**
Migratory thrombophlebitis is a classic example of a paraneoplastic syndrome, which is a condition that occurs in response to a malignancy but is not directly caused by the tumor. It is essential to consider this condition in the differential diagnosis of patients with recurrent episodes of pain and swelling, particularly in the context of a known malignancy.
**Correct Answer:** D.